The document discusses compensation guidelines for injuries or deaths that occur during clinical trials in India. It outlines the following key points:
1. As per Drug and Cosmetics Rules, subjects injured during a trial are entitled to financial compensation above medical expenses to be paid by the trial sponsor.
2. An independent expert committee evaluates serious adverse events and deaths to determine the cause and compensation amount.
3. Formulas have been developed to calculate compensation for deaths based on the subject's age and health, and for disabilities based on percentage of disability.
4. Compensation for life-threatening diseases is linked to hospitalization days, and compensation for birth defects is also based on the severity of outcome and need for